A study by Tokushima University and Kyoto Prefectural University of Medicine has revealed that curcumin, a component of curry powder, reduces the risk of developing relatively large adenomas (polyps), which are precancerous lesions of the colorectal adenoma.
India has long had a low incidence of colorectal cancer, and this has been linked to the cancer-suppressing effects of curcumin, known as the yellow component of curry powder. However, until now, no large-scale randomized controlled trials have been conducted to verify the antitumor effects of curcumin.
In this study, a large-scale, double-blind, randomized controlled trial was conducted over two years involving 26 facilities nationwide, using "Theracurmin®," a highly absorbable curcumin with improved absorption compared to regular curcumin. While most colorectal cancers develop via colorectal adenomas, the development of new adenomas after adenoma removal is a significant problem. Therefore, approximately 600 patients who had undergone prior adenoma removal were randomly assigned to either a group receiving "Theracurmin®" or a placebo group to verify its effect in suppressing the development of new colorectal adenomas.
As a result, there was no significant difference in the overall incidence of colorectal adenomas after two years. However, the incidence of large adenomas (6 mm or larger) requiring endoscopic resection was significantly lower in the curcumin group (7.5%) compared to the placebo group (13.3%), representing an approximately 44% reduction in risk. Furthermore, the number of adenomas larger than 6 mm was significantly lower in the curcumin group, and the overall size of the adenomas that did occur was also significantly smaller. These results suggest that curcumin may not completely prevent the development of adenomas, but rather may suppress the growth and progression of adenomas associated with the future risk of cancer.
In addition, patients with a higher number of previously removed colorectal adenomas tended to show a greater effect of curcumin in suppressing adenoma recurrence. This suggests that curcumin may be more effective for high-risk patients who experience repeated colorectal adenomas. Furthermore, no increase in adverse events (side effects) was observed with curcumin administration, confirming its good safety profile.
Further investigation into the potential preventative effects of curcumin on colorectal cancer is expected to lead to the development of safe and innovative methods for preventing colorectal cancer.
